Editorial Staff

Editor Barbara Zeiger

Assistant Editor Lauren Mateja

Web Content Coordinator Katherine Blessing

Editorial Correspondence

Barbara Zeiger, Editor, OWM

HMP Communications, 70 E Swedesford Rd
Suite 100, Malvern PA, 19355

Telephone: (800) 237-7285 or
(610) 560-0500, ext. 4244
Fax: (610) 560-0501

Email: bzeiger@hmpcommunications.com

November 2012 | Volume 58 - Issue 11

Giant Ulcerating Squamous Cell Carcinoma Arising From Linear Porokeratosis: A Case Study

Abstract

  Linear porokeratosis is one of the infrequent variants of porokeratosis, a rare disorder of keratinization that may develop into several epidermal malignancies, among them squamous cell carcinoma. Clinical surveillance for malignancy is imperative, but in cases when large or many lesions are present, surgical removal of porokeratosis lesions would result in an unfavorable amount of scarring....

An In vitro Assessment of MRI Issues at 3-Tesla for Antimicrobial, Silver-Containing Wound Dressings

Abstract

  Although no reports of adverse events have been published to date, the presence of metallic dressing ingredients may present an magnetic resonance imaging (MRI) safety concern for patients using silver-containing wound dressings. The purpose of this in vitro study was to test magnetic field interactions (ie, translational attraction and torque), heating, artifacts, and conductivity (ie, electrical resistance) when using MRI at 3-Tesla for two (nonborder and border) silver-containing wound dressings....

An In vitro Quantification of Pressures Exerted by Earlobe Pulse Oximeter Probes Following Reports of Device-related Pressure Ulcers in ICU Patients

Abstract

  The earlobe often is used to monitor perfusion when pulse oximeter signal quality is impaired in the fingers and toes. Prompted by intermittent occurrences of roughly circular earlobe pressure ulcers among patients in intensive care units, a convenience sample of seven calibrated pulse oximeter probes was used to quantify earlobe pressure exerted by these devices in vitro....

Guest Editorial: Pursuing Timely Endeavors

  Welcome to the Annual AAWC focus issue of OWM. It is my pleasure to provide an overview of the affairs of the Association for the Advancement of Wound Care (AAWC). As the first podiatrist President of the AAWC and with support from the AAWC Board of Directors, we are creating a platform to address the escalating epidemic of diabetic foot complications and fostering amputation prevention. By promoting a multidisciplinary approach and working in tandem with like-minded organizations, we can initiate a meaningful network, strengthen our efforts, and create a pathway to help diminish the suffering of individuals with this disease....

From the Top: Inspiring Accomplishments

  The Association for the Advancement of Wound Care (AAWC) has accomplished something few associations can achieve. Over the last year-and-a-half, membership in the AAWC has increased 45%. That number speaks volumes. Our leadership’s careful planning and reactive efforts to the economic challenges affecting AAWC’s membership several years ago resulted in the highest membership total in AAWC’s history. We have many to thank for this achievement....

Pearls for Practice: Advancing the Science of Wound Bed Preparation for Chronic Wounds

  Wound healing is the result of dynamic interactive processes that begin at the moment of wounding and involve soluble mediators, many cell types, and extracellular matrices.1 When a wound proceeds through an orderly and timely reparative process and results in a sustained restoration of anatomic and functional integrity, it has been labeled an acute wound.2 Conversely, a chronic wound is one that has failed to proceed through an orderly and timely process to produce anatomic and functional integrity or has proceeded through the repair process without establishing a sustained anatomic and functional result. Therefore, it is important to understand the various events involved in wound healing in order to select the most appropriate wound treatment.3 ...

Continence Coach: Treating Overactive Bladder: A New Tool in Your Toolkit

  Considering the wide choice of prescription drugs on the market for overactive bladder (OAB) symptoms of urge urinary incontinence, urgency, and urinary frequency, one might wonder why yet another has received US Food and Drug Administration (FDA) clearance. Late June 2012, Astellas Pharma US, Inc (Northbrook, IL), a US subsidiary of Tokyo-based Astellas Pharma Inc, announced FDA approval of Myrbetriq™ (mirabegron) extended-release tablets for the treatment of OAB. Allowing time for filling pipelines to pharmacies, the drug should be generally available by year’s end 2012....

My Scope of Practice: Once and Always a Nurse

‘Tis not enough to help the feeble up, but to support them after. — William Shakespeare

  At 7 years old, Debra (Debbie) Siddi, now RN, CWON, knew she wanted to be a nurse. She charted her course through life accordingly. She didn’t wait until she graduated high school — during her junior and senior years, she attended the New York State’s Board of Cooperative Educational Services Licensed Practical Nurse program, graduating with an LPN degree in 1973. After high school, she attended Mount Saint Mary College (Newburgh, NY); in 1977, she earned her Bachelor of Science in Nursing, as well as her Registered Nurse (RN) license....

AAWC Update

 The Association for the Advancement of Wound Care (AAWC) is pleased to present an extended news and information section for this year’s AAWC Focus Issue of OWM. We hope we arouse your interest in our organization and that you will decide to join the 2,000+ wound care professionals and others dedicated to the advancement of wound care....

Can We Talk?: Do Pressure Ulcer Prevention Protocols Improve Patient Care but Increase Institutional Risk?

  Pressure ulcers are a serious cause of morbidity and cost across all healthcare settings in the United States.1 They are more likely to occur among the elderly, and because the US population age 65 years and older is expected to double within the next 25 years, the number of people with pressure ulcers also is expected to increase.2 Data suggest the incidence of skin breakdown can be reduced with the implementation of protocolized care. Driven in part by legislative initiatives, many institutions have developed pressure ulcer prevention protocols.3 It seems difficult to argue these initiatives can be anything other than good for patients. However, even though pressure ulcer prevention protocols may decrease the incidence of some types of skin breakdown, the frequency of litigation involving pressure ulcers is increasing. Why?...